Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation therapy for brain metastases

J G Cairncross, J H Kim, J B Posner

    Annals of Neurology
    |June 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    High-dose whole-brain radiation therapy (RT) and steroids improved neurological function in 74% of brain metastases patients. However, systemic disease, not brain progression, ultimately limited survival.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.

    Cell proliferation·2016
    Same author

    Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

    Neurology·2011
    Same author

    The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.

    British journal of cancer·2007
    Same author

    Low-grade gliomas in children: tumor volume response to radiation.

    Neurosurgical focus·2006
    Same author

    A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.

    Journal of neuro-oncology·2006
    Same author

    Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004
    Same journal

    Diabetes and the Metabolic Syndrome as Drivers of Neurodegeneration: Convergent Mechanisms Linking Peripheral Neuropathy and Dementia.

    Annals of neurology·2026
    Same journal

    Sex Differences in the Association of Simultaneous Decline in Blood Pressure and Decline in Cognition during Aging.

    Annals of neurology·2026
    Same journal

    Neurophysiological Recovery Following Nerve Transfer Surgery to Restore Upper Limb Function after Cervical Spinal Cord Injury.

    Annals of neurology·2026
    Same journal

    A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

    Annals of neurology·2026
    Same journal

    Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

    Annals of neurology·2026
    Same journal

    AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.

    Annals of neurology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Neurology
    • Radiotherapy

    Background:

    • Brain metastases significantly impact patient prognosis and quality of life.
    • Effective management strategies for brain metastases are crucial for improving patient outcomes.

    Purpose of the Study:

    • To evaluate the efficacy of a new high-dose whole-brain radiation therapy (RT) protocol combined with adrenocorticosteroids in patients with brain metastases.
    • To assess the impact of this treatment on neurological function, survival, and patterns of failure.

    Main Methods:

    • A cohort of 183 patients with brain metastases received whole-brain radiation therapy (RT) and adrenocorticosteroids.
    • Neurological status, survival, and causes of death were meticulously documented.

    Main Results:

    Related Experiment Videos

    • Neurological improvement was observed in 74% of patients, with two-thirds maintaining improvement long-term.
    • Clinical responses correlated with tumor regression on CT scans.
    • Median survival was 12 weeks; 24% survived six months and 8% survived one year.
    • The primary cause of death was advancing systemic disease in 66% of patients, despite stable neurological function.

    Conclusions:

    • Whole-brain radiation therapy (RT) combined with adrenocorticosteroids offers significant neurological benefits for patients with brain metastases.
    • Systemic cancer progression, rather than central nervous system disease, is the main determinant of survival in these patients.
    • Further research into systemic treatments is warranted to improve overall survival.